BACKGROUND: Screening for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) in men who have sex with men is risk based. Despite high frequencies of oral and receptive anal intercourse (RAI) among women, extragenital screening is not recommended. METHODS: Women (n = 175) and men who have sex with men (n = 224) primarily recruited from a sexually transmitted infection clinic reporting a lifetime history of RAI completed a structured questionnaire and clinician-collected swab samples from the rectum, pharynx, vagina (women), and urine (men). CT and GC were detected using 2 commercial nucleic acid amplification tests (Aptima Combo 2; Hologic, Inc, Bedford, MA; Xpert CT/NG, Cepheid Innovation, Sunnyvale, CA). RESULTS: The median age of the population was 26 years, 62% were white, and 88% were enrolled from a sexually transmitted disease clinic. Men were more likely than women to have GC (22.8% vs. 3.4%) and CT (21.9% vs. 12.6%). In men versus women, GC was detected in 16.5% versus 2.3% of pharyngeal swabs, 11.6% versus 2.3% of rectal swabs, and 5.4% versus 2.9% of urine samples or vaginal swabs. C. trachomatis was detected in 2.2% versus 1.7% of pharyngeal swabs, 17.4% versus 11.4% of rectal swabs, and 4.5% versus 10.3% for urogenital sites in men versus women. Overall 79.6% of CT and 76.5% of GC in men and 18.2% of CT and 16.7% of GC in women were detected only in the pharynx or rectum. CONCLUSION: Reliance on urogenital screening alone misses most of GC and CT in men and more than 15% of infections in women reporting RAI.
BACKGROUND: Screening for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) in men who have sex with men is risk based. Despite high frequencies of oral and receptive anal intercourse (RAI) among women, extragenital screening is not recommended. METHODS:Women (n = 175) and men who have sex with men (n = 224) primarily recruited from a sexually transmitted infection clinic reporting a lifetime history of RAI completed a structured questionnaire and clinician-collected swab samples from the rectum, pharynx, vagina (women), and urine (men). CT and GC were detected using 2 commercial nucleic acid amplification tests (Aptima Combo 2; Hologic, Inc, Bedford, MA; Xpert CT/NG, Cepheid Innovation, Sunnyvale, CA). RESULTS: The median age of the population was 26 years, 62% were white, and 88% were enrolled from a sexually transmitted disease clinic. Men were more likely than women to have GC (22.8% vs. 3.4%) and CT (21.9% vs. 12.6%). In men versus women, GC was detected in 16.5% versus 2.3% of pharyngeal swabs, 11.6% versus 2.3% of rectal swabs, and 5.4% versus 2.9% of urine samples or vaginal swabs. C. trachomatis was detected in 2.2% versus 1.7% of pharyngeal swabs, 17.4% versus 11.4% of rectal swabs, and 4.5% versus 10.3% for urogenital sites in men versus women. Overall 79.6% of CT and 76.5% of GC in men and 18.2% of CT and 16.7% of GC in women were detected only in the pharynx or rectum. CONCLUSION: Reliance on urogenital screening alone misses most of GC and CT in men and more than 15% of infections in women reporting RAI.
Authors: Courtney M Giannini; Hye K Kim; Jonathan Mortensen; Joel Mortensen; Keith Marsolo; Jill Huppert Journal: J Pediatr Adolesc Gynecol Date: 2010-08 Impact factor: 1.814
Authors: Jennifer Gratrix; Ameeta E Singh; Joshua Bergman; Cari Egan; Justin McGinnis; Steven J Drews; Ron Read Journal: Sex Transm Dis Date: 2014-10 Impact factor: 2.830
Authors: Joshua D Trebach; C Patrick Chaulk; Kathleen R Page; Susan Tuddenham; Khalil G Ghanem Journal: Sex Transm Dis Date: 2015-05 Impact factor: 2.830
Authors: Lisa A Cosentino; Tracy Campbell; Abi Jett; Ingrid Macio; Tracy Zamborsky; Ross D Cranston; Sharon L Hillier Journal: J Clin Microbiol Date: 2012-04-04 Impact factor: 5.948
Authors: N T Annan; A K Sullivan; A Nori; P Naydenova; S Alexander; A McKenna; B Azadian; S Mandalia; M Rossi; H Ward; N Nwokolo Journal: Sex Transm Infect Date: 2009-01-28 Impact factor: 3.519
Authors: Ryan Colby Passaro; Eddy R Segura; Amaya Perez-Brumer; Jeanne Cabeza; Silvia M Montano; Jordan E Lake; Jorge Sanchez; Javier R Lama; Jesse L Clark Journal: Sex Transm Dis Date: 2018-09 Impact factor: 2.830
Authors: Claire C Bristow; Mark R McGrath; Adam C Cohen; Laura J Anderson; Kristie K Gordon; Jeffrey D Klausner Journal: Sex Transm Dis Date: 2017-07 Impact factor: 2.830
Authors: Lisa A Cosentino; Claire S Danby; Lorna K Rabe; Ingrid Macio; Leslie A Meyn; Harold C Wiesenfeld; Sharon L Hillier Journal: J Clin Microbiol Date: 2017-07-05 Impact factor: 5.948
Authors: Nikki N Jordan; Mary Jett-Goheen; Yu-Hsiang Hsieh; Joel C Gaydos; Charlotte A Gaydos Journal: Sex Transm Dis Date: 2020-04 Impact factor: 3.868
Authors: Chelsea L Shannon; Erin M Keizur; Anne Fehrenbacher; Drew Wood-Palmer; Wilson Ramos; Maryann Koussa; Jasmine Fournier; Sung-Jae Lee; Dhara Patel; Whitney N Akabike; Sue Ellen Abdalian; Mary Jane Rotheram-Borus; Jeffrey D Klausner Journal: Sex Transm Dis Date: 2019-11 Impact factor: 3.868